NASDAQ Bull Market Sends Stocks Soaring 🔥

We're seeing several triple-digit gainers in today's premarket. Get the details inside... [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Today is Thursday, August 11th. Let's get ready to trade! Markets 📈 US index rebounded to post solid gains on Wednesday. The S&P 500 jumped 2.1%, and the Nasdaq rallied to a 2.9% gain. The Dow closed with a 1.6% advance, and the small-cap Russell 2K added 3.0% on the day. Today, futures are on the rise again after yesterday's rally officially ended the Nasdaq's longest bear market run since 2008. S&P 500 and Nasdaq-100 contracts are currently showing a 0.3% gain. Sponsored [Five Dividend Stocks to Buy Now (FREE INSIDE)]( Income expert Marc Lichtenfeld is giving away his Ultimate Dividend Package. Inside, you'll get the names and ticker symbols of his TOP FIVE dividend stocks right now, including an "A"-rated, ultra-safe dividend stock with a huge 8% yield. Plus, you'll also get his No. 1 dividend stock for a LIFETIME of income. You could start collecting steady dividend payments as soon as next week if you take action now. [Get the Complete Watchlist Here]( Premarket Highlights 🔎 - The Nasdaq officially entered a bull market yesterday, ending its longest bear market run since 2008 after Wednesday's 2.9% gain. - The US Securities and Exchange Commission is considering a proposal that would require large hedge funds to report their crypto holdings through confidential filings. What to Watch Today 👀 Rebound Rally Yesterday's July CPI data showed inflation cooled to 8.5% from 9.1% in June, and the news sparked a sharp rally across most of America's large-cap benchmark indexes. Investors are hoping the improvement will make the Fed reconsider its aggressive rate-hiking agenda, but 8.5% is still unacceptably high so they can't sit on their heels just yet. We'll get more inflation data today at 8:30 a.m. when the Producer Price Index report for July comes out. Keep an eye on the data because it will probably set the tone for today's trading session. International 🌍 Asia Hong Kong's Hang Seng rallied 2.4% overnight, while Mainland China's Shanghai Composite added 1.6%. Australia's ASX 200 gained 1.1%. Europe The UK FTSE-100 is down 0.3%, and France's CAC 40 is showing a 0.3% loss. The Euro Stoxx 600 is down 0.1%. Major Earnings 💰 - Brookfield Asset Management [BAM] ... AM - Cardinal Health [CAH] ... AM - Canada Goose [GOOS] ... AM - Siemens [SIEGY] ... AM - Utz Brands [UTZ] ... AM - Six Flags Entertainment [SIX] ... AM - Warby Parker [WRBY] ... AM - US Foods [USFD] ... AM - Dillard's [DDS] ... AM Economy 🏗 - Initial jobless claims [Aug] ... 8:30a - Continuing jobless claims [Jul] ... 8:30a - Producer price index [Jul] ... 8:30a Running Hot 🔥 Gainers - AcelRx [ACRX] >> +70.2% - Timber Pharmaceuticals [TMBR] >> +21.7% - Esports Entertainment [GMBL] >> +33.3% Decliners - Athenex [ATNX] >> (35.3%) - InVitae Corp [NVTA] >> (18.5%) - Sonos Inc [SONO] >> (17.8%) Walt Disney Co [DIS] - Last Close: $112.43 Disney is taking off after a strong earnings report. The media giant reported its Q3 earnings after Wednesday's closing bell, and the results blew away the Street. Disney's adjusted EPS came in at $1.09 for the quarter on revenues of $21.5 billion, which easily beat analysts' target of $0.99 EPS on revenues of $21 billion. Perhaps most notable, Disney reported strong growth from its Disney+ division. The streaming service added 14.4 million subscribers, bringing its total subscriber count to 221 million. DIS is leading the S&P 500 with an 8.9% gain after the earnings report. My Take: Disney has had a rough run, but its streaming service is booming and even its parks are starting to show signs of life. The company is still a bit overpriced, but I think this is a high-quality long-term holding, if you can get in at a good price point. Cyclacel Pharmaceuticals [CYCC] - Last Close: $1.33 A better-than-expected earnings report is giving Cyclacel Pharma a premarket boost. The clinical-stage biotech firm is taking off after releasing its Q2 results and a key business update. Cyclacel reported a quarterly loss of $0.46 per share, which beat the Street's prediction of a $0.63 per share loss. The company also said it expects its current cash runway will carry it through to the second half of 2023. Cyclacel also shared updates on its drug pipeline and discussed other areas of the business as part of the report. CYCC is trading actively with a 19.6% gain on the news. My Take: Cyclacel's thinning operating loss is certainly a good sign, but this company still has a long way to go before it makes the big time. Pasithea Therapeutics Corp [KTTA] - Last Close: $1.17 Strong clinical data is rallying Pasithea Therapeutics in today's premarket. The biotech company announced results from a preliminary proof of concept study of PAS002, a vaccine for multiple sclerosis or MS. The preclinical data showed the drug candidate's engineered DNA plasmids provided a high level of efficacy in reducing MS severity and incidence of relapse. A statistically significant reduction in disease and relapse severity was observed compared to the control. Pasithea says it plans to present data from the study in upcoming pharma conferences, and it will submit the full data for peer review. News of the strong drug data is lifting KTTA to a 22.2% gain on active trading volume. My Take: This could be a good way to get in on the ground floor of a speculative pharma play. If this treatment actually gets off the ground, it could drive share prices up a long way. T2 Biosystems [TTOO] - Last Close: $0.158 T2 Biosystems is running hot after a big announcement. The in-vitro diagnostics company said Tuesday that it would explore the potential to develop a rapid molecular diagnostic test for monkeypox. T2 Bio says it has corresponded with the US Food & Drug Administration and the Center for Disease Control and Prevention, and it is exploring developing and commercializing a testing solution for the virus. The Tuesday announcement lifted the stock to a 30.6% gain on Wednesday, and it's carrying the momentum into today's premarket trading session. TTOO is one of this morning's most active stocks, and it's currently showing a 35.4% gain. My Take: Sounds like hype is the biggest reason for this move. However, TTOO also has a high short percentage at 9.6%. I think this stock's outsized move can be attributed to a short squeeze and the general hype surrounding monkeypox-related stocks. Invite Your Friends to Join Elite Trade Club and [Start Earning Valuable Rewards Now!](elitetrade.club/referral/?email={EMAIL}) [Image](elitetrade.club/referral/?email={EMAIL}) That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](